Intellipharmaceutics: Intellipharmaceutics Announces Second Quarter 2023 Results
Intellipharmaceutics International Inc. today reported the results of operations for the three and six months ended May 31, 2023.
Read full article »
Intellipharmaceutics is a Canada-based pharmaceutical company that researches and develops oral solid dosage drugs for the treatment of neurology and cardiovascular disorders.
Read more